Logo image of IAS

INTEGRAL AD SCIENCE HOLDING (IAS) Stock Fundamental Analysis

NASDAQ:IAS - Nasdaq - US45828L1089 - Common Stock

10.15  +0.11 (+1.1%)

After market: 10.45 +0.3 (+2.96%)

Fundamental Rating

5

Taking everything into account, IAS scores 5 out of 10 in our fundamental rating. IAS was compared to 92 industry peers in the Media industry. IAS has an excellent financial health rating, but there are some minor concerns on its profitability. IAS shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year IAS was profitable.
IAS had a positive operating cash flow in the past year.
In multiple years IAS reported negative net income over the last 5 years.
Of the past 5 years IAS 4 years had a positive operating cash flow.
IAS Yearly Net Income VS EBIT VS OCF VS FCFIAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 50M -50M 100M

1.2 Ratios

IAS has a Return On Assets of 2.88%. This is in the better half of the industry: IAS outperforms 74.71% of its industry peers.
The Return On Equity of IAS (3.33%) is better than 62.07% of its industry peers.
With a Return On Invested Capital value of 3.69%, IAS perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
Industry RankSector Rank
ROA 2.88%
ROE 3.33%
ROIC 3.69%
ROA(3y)-0.9%
ROA(5y)-2.48%
ROE(3y)-1.38%
ROE(5y)-4.56%
ROIC(3y)N/A
ROIC(5y)N/A
IAS Yearly ROA, ROE, ROICIAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -2 -4 -6 -8 -10

1.3 Margins

Looking at the Profit Margin, with a value of 6.39%, IAS is in the better half of the industry, outperforming 73.56% of the companies in the same industry.
Looking at the Operating Margin, with a value of 9.81%, IAS is in the better half of the industry, outperforming 63.22% of the companies in the same industry.
The Gross Margin of IAS (78.71%) is better than 90.80% of its industry peers.
In the last couple of years the Gross Margin of IAS has declined.
Industry RankSector Rank
OM 9.81%
PM (TTM) 6.39%
GM 78.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5YN/A
IAS Yearly Profit, Operating, Gross MarginsIAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IAS is destroying value.
The number of shares outstanding for IAS has been increased compared to 1 year ago.
IAS has a better debt/assets ratio than last year.
IAS Yearly Shares OutstandingIAS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
IAS Yearly Total Debt VS Total AssetsIAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

IAS has an Altman-Z score of 7.25. This indicates that IAS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of IAS (7.25) is better than 93.10% of its industry peers.
IAS has a debt to FCF ratio of 0.93. This is a very positive value and a sign of high solvency as it would only need 0.93 years to pay back of all of its debts.
IAS's Debt to FCF ratio of 0.93 is amongst the best of the industry. IAS outperforms 88.51% of its industry peers.
IAS has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
IAS's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. IAS outperforms 78.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.93
Altman-Z 7.25
ROIC/WACC0.42
WACC8.78%
IAS Yearly LT Debt VS Equity VS FCFIAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

IAS has a Current Ratio of 3.71. This indicates that IAS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.71, IAS belongs to the top of the industry, outperforming 91.95% of the companies in the same industry.
IAS has a Quick Ratio of 3.71. This indicates that IAS is financially healthy and has no problem in meeting its short term obligations.
IAS has a better Quick ratio (3.71) than 91.95% of its industry peers.
Industry RankSector Rank
Current Ratio 3.71
Quick Ratio 3.71
IAS Yearly Current Assets VS Current LiabilitesIAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

7

3. Growth

3.1 Past

IAS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 300.00%, which is quite impressive.
IAS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.77%.
Measured over the past years, IAS shows a very strong growth in Revenue. The Revenue has been growing by 25.39% on average per year.
EPS 1Y (TTM)300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%211.11%
Revenue 1Y (TTM)11.77%
Revenue growth 3Y25.39%
Revenue growth 5YN/A
Sales Q2Q%10.97%

3.2 Future

IAS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 122.53% yearly.
IAS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.65% yearly.
EPS Next Y516.83%
EPS Next 2Y189.69%
EPS Next 3Y122.53%
EPS Next 5YN/A
Revenue Next Year11.56%
Revenue Next 2Y11.76%
Revenue Next 3Y11.9%
Revenue Next 5Y10.65%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IAS Yearly Revenue VS EstimatesIAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
IAS Yearly EPS VS EstimatesIAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 50.75 indicates a quite expensive valuation of IAS.
IAS's Price/Earnings is on the same level as the industry average.
IAS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.29.
A Price/Forward Earnings ratio of 30.24 indicates a quite expensive valuation of IAS.
IAS's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of IAS to the average of the S&P500 Index (24.44), we can say IAS is valued slightly more expensively.
Industry RankSector Rank
PE 50.75
Fwd PE 30.24
IAS Price Earnings VS Forward Price EarningsIAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

IAS's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IAS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 23.92
EV/EBITDA 14.67
IAS Per share dataIAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IAS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IAS's earnings are expected to grow with 122.53% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y189.69%
EPS Next 3Y122.53%

0

5. Dividend

5.1 Amount

IAS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTEGRAL AD SCIENCE HOLDING

NASDAQ:IAS (1/21/2025, 8:06:33 PM)

After market: 10.45 +0.3 (+2.96%)

10.15

+0.11 (+1.1%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners57.28%
Inst Owner Change-0.01%
Ins Owners0.41%
Ins Owner Change15.25%
Market Cap1.65B
Analysts80
Price Target15.03 (48.08%)
Short Float %5.83%
Short Ratio5.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)72.96%
Min EPS beat(2)38.96%
Max EPS beat(2)106.96%
EPS beat(4)3
Avg EPS beat(4)41.66%
Min EPS beat(4)-17.87%
Max EPS beat(4)106.96%
EPS beat(8)6
Avg EPS beat(8)-181.32%
EPS beat(12)8
Avg EPS beat(12)-116.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.55%
Min Revenue beat(2)-4.27%
Max Revenue beat(2)1.17%
Revenue beat(4)3
Avg Revenue beat(4)-0.18%
Min Revenue beat(4)-4.27%
Max Revenue beat(4)1.27%
Revenue beat(8)7
Avg Revenue beat(8)1.41%
Revenue beat(12)11
Avg Revenue beat(12)1.93%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.56%
PT rev (3m)-7.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.8%
EPS NY rev (1m)0%
EPS NY rev (3m)21.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.77%
Valuation
Industry RankSector Rank
PE 50.75
Fwd PE 30.24
P/S 3.23
P/FCF 23.92
P/OCF 15.32
P/B 1.68
P/tB 15.76
EV/EBITDA 14.67
EPS(TTM)0.2
EY1.97%
EPS(NY)0.34
Fwd EY3.31%
FCF(TTM)0.42
FCFY4.18%
OCF(TTM)0.66
OCFY6.53%
SpS3.14
BVpS6.04
TBVpS0.64
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.88%
ROE 3.33%
ROCE 4.67%
ROIC 3.69%
ROICexc 3.9%
ROICexgc 28.44%
OM 9.81%
PM (TTM) 6.39%
GM 78.71%
FCFM 13.5%
ROA(3y)-0.9%
ROA(5y)-2.48%
ROE(3y)-1.38%
ROE(5y)-4.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5YN/A
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.93
Debt/EBITDA 0.57
Cap/Depr 62.84%
Cap/Sales 7.57%
Interest Coverage 7.2
Cash Conversion 96.39%
Profit Quality 211.18%
Current Ratio 3.71
Quick Ratio 3.71
Altman-Z 7.25
F-Score7
WACC8.78%
ROIC/WACC0.42
Cap/Depr(3y)38.82%
Cap/Depr(5y)28.35%
Cap/Sales(3y)5.14%
Cap/Sales(5y)4.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%211.11%
EPS Next Y516.83%
EPS Next 2Y189.69%
EPS Next 3Y122.53%
EPS Next 5YN/A
Revenue 1Y (TTM)11.77%
Revenue growth 3Y25.39%
Revenue growth 5YN/A
Sales Q2Q%10.97%
Revenue Next Year11.56%
Revenue Next 2Y11.76%
Revenue Next 3Y11.9%
Revenue Next 5Y10.65%
EBIT growth 1Y396.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year954.16%
EBIT Next 3Y137.95%
EBIT Next 5Y75.34%
FCF growth 1Y15.78%
FCF growth 3Y59.15%
FCF growth 5YN/A
OCF growth 1Y46.6%
OCF growth 3Y57.11%
OCF growth 5YN/A